The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Prebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer
Abstract
While microbial‐based therapy has been considered as an effective strategy for treating diseases such as colon cancer, its safety remains the biggest challenge. Here, probiotics and prebiotics, which possess ideal biocompatibility and are extensively used as additives in food and pharmaceutical products, are combined to construct a safe microbiota‐modulating material. Through the host–guest chemistry between commercial Clostridium butyricum and chemically modified prebiotic dextran, prebiotics‐encapsulated probiotic spores (spores‐dex) are prepared. It is found that spores‐dex can specifically enrich in colon cancers after oral administration. In the lesion, dextran is fermented by C. butyricum , and thereby produces anti‐cancer short‐chain fatty acids (SCFAs). Additionally, spores‐dex regulate the gut microbiota, augment the abundance of SCFA‐producing bacteria (e.g., Eubacterium and Roseburia ), and markedly increase the overall richness of microbiota. In subcutaneous and orthotopic tumor models, drug‐loaded spores‐dex inhibit tumor growth up to 89% and 65%, respectively. Importantly, no obvious adverse effect is found. The work sheds light on the possibility of using a highly safe strategy to regulate gut microbiota, and provides a promising avenue for treating various gastrointestinal diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prebiotics are a group of substances that can be used by host bacteria to enhance the proportion of beneficial species to improve the anti-tumor immunity13–15.”
From Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy (2023) · cites this paper as [14]
Citations
Cites
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Diet-induced extinctions in the gut microbiota compound over generations
Sonnenburg, E. D., Smits, S. A., Tikhonov, M., Higginbottom, S. K., Wingreen, N. S., & Sonnenburg, J. L. (2016) · Nature · doi:10.1038/nature16504 · Cited by 1,730
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0423-2 · Cited by 495
Self-citation
Flagged first, then by citations
Research works printed but not linked: 32
- 10.1038/s41575-019-0121-2 · DOI
- 10.1038/nature11552 · DOI · Paper page
- 10.1038/s41591-019-0377-7 · DOI · Paper page
- 10.1038/s41551-020-0582-1 · DOI
- 10.1038/s41564-019-0649-5 · DOI · Paper page
- 10.1038/s41467-017-00729-8 · DOI · Paper page
- 10.1126/scitranslmed.aap9489 · DOI
- 10.1016/j.tim.2014.04.003 · DOI
- 10.1038/s41565-019-0589-5 · DOI
- 10.1016/S1470-2045(18)30952-5 · DOI · Paper page
- 10.1002/adma.201808278 · DOI
- 10.1021/acs.nanolett.7b05323 · DOI
- Chen Q. W., 2020, Adv. Funct. Mater., 30, 201909806
- 10.1038/s41563-019-0462-9 · DOI
- 10.1038/nnano.2016.137 · DOI
- 10.1038/s41575-019-0173-3 · DOI · Paper page
- 10.1038/s41586-018-0774-y · DOI · Paper page
- 10.1021/acs.nanolett.6b01432 · DOI
- 10.1021/jacs.9b01993 · DOI
- 10.1002/adma.201603270 · DOI
- 10.1128/mBio.01315-19 · DOI
- 10.1021/acs.nanolett.8b01892 · DOI
- 10.1038/nbt937 · DOI
- 10.1038/s41467-019-13727-9 · DOI
- 10.1038/s41573-019-0053-0 · DOI
- 10.1016/j.biomaterials.2019.119247 · DOI
- 10.1126/scitranslmed.3008778 · DOI
- Meng J., 2019, Front. Immunol., 10, 2999, 10.3389/fimmu.2019.02999 · DOI
- 10.1007/s00394-019-01938-1 · DOI
- 10.1073/pnas.1419341112 · DOI
- Michael K., 2018, Curr. Opin. Microbiol., 44, 34, 10.1016/j.mib.2018.07.003 · DOI
- Ng K. M., 2019, Cell Host Microbe, 26, 650, 10.1016/j.chom.2019.10.011 · DOI
Cited by
Sorted by citations
Lang, T., Zhu, R., Zhu, X., Yan, W., Li, Y., Zhai, Y., Wu, T., Huang, X., Yin, Q., & Li, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-40439-y · Cited by 133
Metadata
- Authors
- Zheng, D., Li, R., An, J., Xie, T., Han, Z., Xu, R., Fang, Y., & Zhang, X.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10
- Volume
- 32
- Issue
- 45
- ISSN
- 0935-9648
- 1521-4095
- Cited by
- 274
- References
- 11
- Language
- en
- Funders
- National Natural Science Foundation of China (51833007, 51690152, 51988102)
- National Basic Research Program of China (2019YFA0905603)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review